rs145733370

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS1

The NM_001256545.2(MEGF10):​c.50G>A​(p.Cys17Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000247 in 1,613,154 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. C17C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00021 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 1 hom. )

Consequence

MEGF10
NM_001256545.2 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:1

Conservation

PhyloP100: 1.09

Publications

3 publications found
Variant links:
Genes affected
MEGF10 (HGNC:29634): (multiple EGF like domains 10) This gene encodes a member of the multiple epidermal growth factor-like domains protein family. The encoded protein plays a role in cell adhesion, motility and proliferation, and is a critical mediator of apoptotic cell phagocytosis as well as amyloid-beta peptide uptake in the brain. Expression of this gene may be associated with schizophrenia, and mutations in this gene are a cause of early-onset myopathy, areflexia, respiratory distress, and dysphagia (EMARDD) as well as congenital myopathy with minicores. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Apr 2012]
MEGF10 Gene-Disease associations (from GenCC):
  • MEGF10-related myopathy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.057441413).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00021 (32/152084) while in subpopulation NFE AF = 0.000441 (30/68030). AF 95% confidence interval is 0.000317. There are 0 homozygotes in GnomAd4. There are 22 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001256545.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MEGF10
NM_001256545.2
MANE Select
c.50G>Ap.Cys17Tyr
missense
Exon 2 of 25NP_001243474.1Q96KG7-1
MEGF10
NM_032446.3
c.50G>Ap.Cys17Tyr
missense
Exon 3 of 26NP_115822.1Q96KG7-1
MEGF10
NM_001308119.2
c.50G>Ap.Cys17Tyr
missense
Exon 3 of 15NP_001295048.1Q96KG7-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MEGF10
ENST00000503335.7
TSL:1 MANE Select
c.50G>Ap.Cys17Tyr
missense
Exon 2 of 25ENSP00000423354.2Q96KG7-1
MEGF10
ENST00000274473.6
TSL:1
c.50G>Ap.Cys17Tyr
missense
Exon 3 of 26ENSP00000274473.6Q96KG7-1
MEGF10
ENST00000418761.6
TSL:1
c.50G>Ap.Cys17Tyr
missense
Exon 3 of 15ENSP00000416284.2Q96KG7-2

Frequencies

GnomAD3 genomes
AF:
0.000210
AC:
32
AN:
152084
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000195
AC:
49
AN:
250982
AF XY:
0.000199
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000423
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000251
AC:
367
AN:
1461070
Hom.:
1
Cov.:
29
AF XY:
0.000217
AC XY:
158
AN XY:
726848
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33442
American (AMR)
AF:
0.0000224
AC:
1
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26106
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39670
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86202
European-Finnish (FIN)
AF:
0.0000374
AC:
2
AN:
53412
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.000320
AC:
356
AN:
1111420
Other (OTH)
AF:
0.0000994
AC:
6
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
14
29
43
58
72
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000210
AC:
32
AN:
152084
Hom.:
0
Cov.:
32
AF XY:
0.000296
AC XY:
22
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41388
American (AMR)
AF:
0.00
AC:
0
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000441
AC:
30
AN:
68030
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000328
Hom.:
0
Bravo
AF:
0.000181
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000206
AC:
25
EpiCase
AF:
0.000164
EpiControl
AF:
0.000357

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
1
not provided (4)
-
1
-
MEGF10-related myopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
15
DANN
Benign
0.30
DEOGEN2
Benign
0.024
T
Eigen
Benign
-0.91
Eigen_PC
Benign
-0.70
FATHMM_MKL
Benign
0.74
D
LIST_S2
Benign
0.53
T
M_CAP
Benign
0.039
D
MetaRNN
Benign
0.057
T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.91
L
PhyloP100
1.1
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-0.11
N
REVEL
Benign
0.19
Sift
Benign
0.74
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.15
MVP
0.12
MPC
0.37
ClinPred
0.015
T
GERP RS
1.3
Varity_R
0.031
gMVP
0.50
Mutation Taster
=71/29
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145733370; hg19: chr5-126667050; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.